Immunohistochemical evaluation of two corneal buttons with post-LASIK keratectasia

Cornea

Volumn 26, Issue 8, 2007, Pages 983-991

  Maguen, Ezra ^a,b   Maguen, Barak ^a   Regev, Lee ^a,c   Ljubimov, Alexander V ^a,b,d  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c American Jewish University   (United States)

^d BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

Author keywords

Basement membrane; Cathepsin; Cellular fibronectin; Ectasia; Fibrosis; Flap interface; Human cornea; Laser in situ keratomileusis; Matrix metalloproteinase

Indexed keywords

ALPHA ENOLASE; COLLAGEN TYPE 14; COLLAGEN TYPE 4 ALPHA2 CHAIN; COLLAGEN TYPE 4 ALPHA5 CHAIN; COLLAGEN TYPE 6; ENTACTIN; FIBRONECTIN; LAMININ; LAMININ 8; NIDOGEN 2; PROTEINASE; STROMELYSIN 2; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTACT LENS; CORNEA CELL; CORNEA DISEASE; CORNEA TRANSPLANTATION; EXTRACELLULAR MATRIX; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KERATETASIA; KERATOMETRY; KERATOMILEUSIS; KERATOPLASTY; MALE; PRIORITY JOURNAL; SLIT LAMP; STAINING;

ADULT; BASEMENT MEMBRANE; BIOLOGICAL MARKERS; CORNEA; CORNEAL TOPOGRAPHY; DILATATION, PATHOLOGIC; EXTRACELLULAR MATRIX PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; KERATOMILEUSIS, LASER IN SITU; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SURGICAL FLAPS;

EID: 34548285031     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3180de1d91     Document Type: Article

References (40)

1. Randleman JB. Post-laser in-situ keratomileusis ectasia: current understanding and future directions. Curr Opin Ophthalmol. 2006;17: 406-412.
2. Schallhorn SC, Amesbury EC, Tanzer DJ. Avoidance, recognition, and management of LASIK complications. Am J Ophthalmol. 2006;141: 733-739.
3. Rabinowitz YS. Ectasia after laser in situ keratomileusis. Curr Opin Ophthalmol. 2006;17:421-426.
4. Srivannaboon S. Flap analysis: critical point in laser in situ keratomileusis. J Med Assoc Thai. 2001;84:1317-1320.
5. Rad AS, Jabbarvand M, Saifi N. Progressive keratectasia after laser in situ keratomileusis. J Refract Surg. 2004;20(5 Suppl):S718-S722.
6. Binder PS, Lindstrom RL, Stulting RD, et al. Keratoconus and corneal ectasia after LASIK. J Refract Surg. 2005;21:749-752.
7. Nesburn AB, Bahri S, Salz J, et al. Keratoconus detected by videokeratography in candidates for photorefractive keratectomy. J Refract Surg. 1995;11:194-201.
8. Choi HJ, Kim MK, Lee JL. Optimization of contact lens fitting in keratectasia patients after laser in situ keratomileusis. J Cataract Refract Surg. 2004;30:1057-1066.
9. O'Donnell C, Welham L, Doyle S. Contact lens management of keratectasia after laser in situ keratomileusis for myopia. Eye Contact Lens. 2004;30:144-146.
10. Lovisolo CF, Fleming JF. Intracorneal ring segments for iatrogenic keratectasia after laser in situ keratomileusis or photorefractive keratectomy. J Refract Surg. 2002;18:535-541.
11. Maguen E, Zorapapel NC, Zieske JD, et al. Extracellular matrix and matrix metalloproteinase changes in human corneas after complicated laser-assisted in situ keratomileusis (LASIK). Cornea. 2002;21:95-100.
12. Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab Invest. 1995;72:461-473.
13. Zieske JD, Bukusoglu G, Yankauckas MA, et al. Alpha-enolase is restricted to basal cells of stratified squamous epithelium. Dev Biol. 1992; 151:18-26.
14. Ljubimov AV, Alba SA, Burgeson RE, et al. Extracellular matrix changes in human corneas after radial keratotomy. Exp Eye Res. 1998;67:265-272.
15. Saghizadeh M, Brown DJ, Castellon R, et al. Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations. Am J Pathol. 2001;158:723-734.
16. Saghizadeh M, Kramerov AA, Tajbakhsh J, et al. Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas. Invest Ophthalmol Vis Sci. 2005;46:3604-3615.
17. Kaspar M, Zardi L, Neri D. Fibronectin as target for tumor therapy. Int J Cancer. 2006;118:1331-1339.
18. Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci. 1996;37:997-1007.
19. Kenney MC, Nesburn AB, Burgeson RE, et al. Abnormalities of the extracellular matrix in keratoconus corneas. Cornea. 1997;16:345-351.
20. Maguen E, Alba SA, Burgeson RE, et al. Alterations of corneal extracellular matrix following multiple refractive procedures: a clinical and immunohistochemical study. Cornea. 1997;16:675-682.
21. Pérez-Santonja JJ, Linna TU, Tervo KM, et al. Corneal wound healing after laser in situ keratomileusis in rabbits. J Refract Surg. 1998;14: 602-609.
22. Ivarsen A, Laurberg T, Møller-Pedersen T. Characterisation of corneal fibrotic wound repair at the LASIK flap margin. Br J Ophthalmol. 2003; 87:1272-1278.
23. Dawson DG, Kramer TR, Grossniklaus HE, et al. Histologic, ultrastructural, and immunofluorescent evaluation of human laser-assisted in situ keratomileusis corneal wounds. Arch Ophthalmol. 2005;123:741-756.
24. Schmack I, Dawson DG, McCarey BE, et al. Cohesive tensile strength of human LASIK wounds with histologic, ultrastructural, and clinical correlations. J Refract Surg. 2005;21:433-445.
25. Priglinger SG, May CA, Alge CS, et al. Immunohistochemical findings after LASIK confirm in vitro LASIK model. Cornea. 2006;25:331-335.
26. Philipp WE, Speicher L, Gottinger W. Histological and immunohistochemical findings after laser in situ keratomileusis in human corneas. J Cataract Refract Surg. 2003;29:808-820.
27. Erie JC, Patel SV, McLaren JW, et al. Corneal keratocyte deficits after photorefractive keratectomy and laser in situ keratomileusis. Am J Ophthalmol. 2006;141:799-809.
28. Kramer TR, Chuckpaiwong V, Dawson DG, et al. Pathologic findings in postmortem corneas after successful laser in situ keratomileusis. Cornea. 2005;24:92-102.
29. May CA, Priglinger SG, Neubauer AS, et al. Laser in situ keratomileusis in human corneas: new organ culture model. J Cataract Refract Surg. 2004;30:179-186.
30. Zhang Y, Schmack I, Dawson DG, et al. Keratan sulfate and chondroitin/ dermatan sulfate in maximally recovered hypocellular stromal interface scars of postmortem human LASIK corneas. Invest Ophthalmol Vis Sci. 2006;47:2390-2396.
31. Kao WW, Vergnes JP, Ebert J, et al. Increased collagenase and gelatinase activities in keratoconus. Biochem Biophys Res Commun. 1982;107: 929-936.
32. Brown D, Chwa MM, Opbroek A, et al. Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors. Curr Eye Res. 1993;12:571-581.
33. Smith VA, Hoh HB, Littleton M, et al. Overexpression of a gelatinase A activity in keratoconus. Eye. 1995;9:429-433.
34. Zhou L, Sawaguchi S, Twining SS, et al. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci. 1998;39:1117-1124.
35. Kenney MC, Chwa M, Atilano SR, et al. Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Invest Ophthalmol Vis Sci. 2005;46:823-832.
36. Mackiewicz Z, Määttä M, Stenman M, et al. Collagenolytic proteinases in keratoconus. Cornea. 2006;25:603-610.
37. Barksby HE, Milner JM, Patterson AM, et al. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Arthritis Rheum. 2006;54: 3244-3253.
38. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. 2006;17:356-360.
39. Goo HC, Hwang YS, Choi YR, et al. Development of collagenase-resistant collagen and its interaction with adult human dermal fibroblasts. Biomaterials. 2003;24:5099-5113.
40. Wallace C, Jacob JT, Stoltz A, et al. Corneal epithelial adhesion strength to tethered-protein/peptide modified hydrogel surfaces. J Biomed Mater Res A. 2005;72:19-24.